Loading...
Bio-Techne Corporation
TECH•NASDAQ
Healthcare
Biotechnology
$58.78
$0.31(0.54%)
Bio-Techne Corporation (TECH) Financial Performance & Income Statement Overview
Review Bio-Techne Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.97%
↑ 1.97%
Operating Income Growth
-30.86%
↓ 30.86%
Net Income Growth
-41.07%
↓ 41.07%
Operating Cash Flow Growth
17.53%
↑ 17.53%
Operating Margin
14.22%
↑ 14.22%
Gross Margin
65.88%
↑ 65.88%
Net Profit Margin
10.89%
↑ 10.89%
ROE
6.34%
↑ 6.34%
ROIC
6.95%
↑ 6.95%
Bio-Techne Corporation (TECH) Income Statement & Financial Overview
Review Bio-Techne Corporation's (TECH) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $297.03M | $289.46M | $306.10M | $303.43M |
| Cost of Revenue | $103.14M | $106.44M | $101.22M | $98.18M |
| Gross Profit | $193.89M | $183.02M | $204.88M | $205.25M |
| Gross Profit Ratio | $0.65 | $0.63 | $0.67 | $0.68 |
| R&D Expenses | $25.02M | $23.87M | $23.99M | $25.76M |
| SG&A Expenses | $121.45M | $119.16M | $101.90M | $107.50M |
| Operating Expenses | $146.47M | $143.03M | $125.89M | $133.27M |
| Total Costs & Expenses | $249.61M | $249.47M | $227.11M | $231.45M |
| Interest Income | $1.35M | $926000.00 | $905000.00 | $712000.00 |
| Interest Expense | $2.15M | $2.18M | $2.51M | $4.005M |
| Depreciation & Amortization | $27.08M | $28.14M | $28.06M | $27.31M |
| EBITDA | $74.92M | $73.86M | $96.76M | $99.33M |
| EBITDA Ratio | $0.25 | $0.26 | $0.32 | $0.33 |
| Operating Income | $47.42M | $39.99M | $78.99M | $71.98M |
| Operating Income Ratio | $0.16 | $0.14 | $0.26 | $0.24 |
| Other Income/Expenses (Net) | -$4.54M | $184000.00 | -$4.16M | -$5.91M |
| Income Before Tax | $42.88M | $40.17M | $41.66M | $61.08M |
| Income Before Tax Ratio | $0.14 | $0.14 | $0.14 | $0.20 |
| Income Tax Expense | $7.99M | $6.57M | $1.07M | $12.03M |
| Net Income | $34.89M | $33.60M | $40.59M | $49.06M |
| Net Income Ratio | $0.12 | $0.12 | $0.13 | $0.16 |
| EPS | $0.22 | $0.21 | $0.26 | $0.31 |
| Diluted EPS | $0.22 | $0.21 | $0.25 | $0.31 |
| Weighted Avg Shares Outstanding | $158.43M | $158.53M | $157.87M | $157.31M |
| Weighted Avg Shares Outstanding (Diluted) | $160.63M | $161.12M | $160.65M | $160.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan